Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length

Trial Profile

Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Dec 2018

At a glance

  • Drugs Progesterone (Primary)
  • Indications Preterm labour
  • Focus Adverse reactions
  • Acronyms Quadruple-P-Study
  • Most Recent Events

    • 30 Nov 2018 Planned number of patients changed from 700 to 960.
    • 12 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top